Homologues of two major components of the well-characterized erythrocyte plasma-membrane-skeleton, spectrin (a not-yet-cloned isoform, ␤I⌺* spectrin) and ankyrin (Ank G119 and an Ϸ195-kDa ankyrin), associate with the Golgi complex. ADP ribosylation factor (ARF) is a small G protein that controls the architecture and dynamics of the Golgi by mechanisms that remain incompletely understood. We find that activated ARF stimulates the in vitro association of ␤I⌺* spectrin with a Golgi fraction, that the Golgiassociated ␤I⌺* spectrin contains epitopes characteristic of the ␤I⌺2 spectrin pleckstrin homology (PH) domain known to bind phosphatidylinositol 4,5-bisphosphate (PtdInsP 2 ), and that ARF recruits ␤I⌺* spectrin by inducing increased PtdInsP 2 levels in the Golgi. The stimulation of spectrin binding by ARF is independent of its ability to stimulate phospholipase D or to recruit coat proteins (COP)-I and can be blocked by agents that sequester PtdInsP 2 . We postulate that a PH domain within ␤I⌺* Golgi spectrin binds PtdInsP 2 and acts as a regulated docking site for spectrin on the Golgi. Agents that block the binding of spectrin to the Golgi, either by blocking the PH domain interaction or a constitutive Golgi binding site within spectrin's membrane association domain I, inhibit the transport of vesicular stomatitis virus G protein from endoplasmic reticulum to the medial compartment of the Golgi complex. Collectively, these results suggest that the Golgi-spectrin skeleton plays a central role in regulating the structure and function of this organelle.
Despite the early recognition of a key role for the small G protein ADP ribosylation factor (ARF) among the molecules controlling the architecture of the Golgi complex (1) , and recent advances in identifying structural components of this organelle (2) (3) , the mechanisms by which such control is effected remain obscure. Recently, homologues of two major components of the well-characterized erythrocyte plasmamembrane-skeleton, spectrin (a not-yet-cloned isoform, hence designed as ␤I⌺* spectrin) and ankyrin (Ank G119 and a Ϸ195-kDa ankyrin) have been identified in the Golgi complex (4-7), and a Golgi-targeting sequence has been identified in spectrin (7) . The molecular mechanisms controlling such localization and its functional role remain incompletely understood.
We now demonstrate a mechanism controlling Golgi spectrin association and investigate the acute effects of the loss of Golgi spectrin binding on intracellular membrane traffic. Spectrin uses at least two sites to bind to Golgi fractions in vitro. One site involves spectrin's membrane association domain (MAD) 1, in accord with studies identifying a Golgitargeting sequence in ␤I⌺* spectrin (7) . The other site involves a pleckstrin homology (PH) domain within the MAD2 of ␤I⌺* spectrin. Binding at MAD2 is regulated by ARF, which recruits spectrin by increasing Golgi phosphatidylinositol 4,5-bisphosphate (PtdInsP 2 ) levels. Inhibitors of spectrin binding to Golgi block endoplasmic reticulum (ER) to Golgi transport of vesicular stomatitis virus (VSV)-G protein. Collectively these results identify a pathway regulating the assembly of the Golgi spectrin-ankyrin skeleton and demonstrate the importance of this complex for Golgi function. Portions of this work have been previously presented in abstract form (8) .
METHODS
Immunof luorescence. NRK cells were left intact or incubated with 1 unit͞ml of Streptolysin O (BioMerieux, Charbonnier les Bains, France) for 8 min at 0°C, washed and permeabilized for 15 min at 37°C in 25 mM Hepes-KOH, pH 6.95͞125 mM KOAc͞2.5 mM Mg(OAc) 2 ͞10 mM glucose͞1 mM DTT͞1 mM ATP͞2 mM creatine phosphate͞7.3 units/ml creatine phosphokinase͞2 mg/ml rat brain or NRK cell cytosol. Cells were fixed in 1.9% paraformaldehyde and permeabilized with 0.01% saponin before immunostaining (7) .
Cytosol and Golgi Fraction Preparation. Golgi fractions were obtained from NRK cells or rat liver (9) (10) . The Golgi-rich fraction from the postnuclear supernatant contained Ͼ90% of the mannosidase II (Golgi marker), 4% of NaK-ATPase or ecto-ATPase HA4 (plasma-membrane marker, ref. 11), and 3% of CaBP1 (an ER marker) (12) . Cytosol was obtained from rat brain, NRK, or RBL cells (9) . ARF-depleted cytosol was prepared (13) . Coatomer-depleted cytosol was prepared by a 20-min 37°C incubation of rat brain cytosol with excess Golgi and 100 M GTP␥S in the absence of ATP and an ATP-regenerating system. Residual coatomer was assessed in cleared cytosol by using anti-␤-coat protein (COP) antibodies. ARF was purified from bovine brain cytosol (14) .
Antibodies and Recombinant Polypeptides. Antibodies used were mAbVIIIC7 (15) and antibody 993 (Chemicon) against ␤I⌺1 spectrin, and three antibodies against the PH domain of ␤I⌺2 spectrin. Specifically used were: MUS1, against a 17-residue peptide (␤I⌺2-A, ref. 16); MUS2, against -LEGPNKKASNR-SWNN..GGC-representing the variable loop between the first and second ␤-sheet of the PH domain (J.S.M. and C. D. Cianci, unpublished work); and PAB-␤I⌺2 DIII , against region III of ␤I⌺2 spectrin (J.S.M. and S. A. Weed, unpublished work). Other antibodies were PAB-jasmin against the Golgi ankyrin Ank G119 (5); PAB-10D against ␤II spectrin (17); anti-␤-COP (M3A5, Sigma), anti-actin (Sigma), anti-centractin (provided by E. Holzbaur, University of Pennsylvania, Philadelphia); and anti-ARF (1D9, provided by R. Kahn, Emory University, Atlanta). Recombinant peptides generated as fusions with glutathione S-transferase (GST) included various ␤I spectrin peptides (7), ␤II spectrin-PH domain (17) , the oxysterol-binding protein (OSBP)-PH domain (18) , and the Bruton's tyrosine kinase (Btk)-PH domain (amino acids 6-217) (19) .
Binding to Golgi. Golgi and cytosol were incubated 25 min at 37°C in binding buffer (25 mM Hepes-KOH, pH 7͞0.2 M sucrose͞25 mM KCl͞2.5 mM MgCl 2 ͞1 mM ATP͞5 mM creatine phosphate͞10 units/ml creatine phosphokinase͞1 mM DTT, and 20 M GTP␥S for the last 10 min). Membranes were pelleted and analyzed by SDS͞PAGE and Western blotting. ␤I⌺* spectrin binding also was assayed on flotation gradients. Samples were made 1.24 M sucrose, overlaid with 1 M sucrose, 0.5 M sucrose, 10 mM Tris⅐HCl, pH 7.4 and centrifuged 120 min at 90,000 ϫ g at 4°C. Interfacial material between 0.5 M and 1 M sucrose was analyzed. ␤I⌺* spectrin was taken as a protein of 220 K d recognized by the ␤I, but not ␤II, reactive antibodies.
Other. Phospholipids were extracted in chloroform͞ methanol and analyzed by TLC (20) , and radioactive products were quantified by using a Packard Instant-Imager. ER-Golgi transport of the G protein of ts045 VSV was measured in semi-intact VSV-infected NRK cells (20) (21) (22) .
RESULTS
Golgi-Associated Spectrin Shares a Close Antigenic Similarity to ␤I⌺2 Spectrin. All ␤I spectrin antibodies labeled Golgi-like perinuclear reticular and punctate structures in NRK cells (Fig. 1) . The Golgi-associated spectrin underwent a diffuse redistribution after treatment with brefeldin A (BFA), a fungal toxin that rapidly disassembles the Golgi complex (4, 23, 24) . The Golgi-like distribution detected by the PH domain-specific spectrin antibodies and the BFA sensitivity suggested that Golgi spectrin must contain a PH domain antigenically similar to that of ␤I⌺2 spectrin. The distribution of Ank G119 , a Golgi-associated ankyrin isoform (5) , paralleled that of spectrin in control and BFA-treated cells (data not shown). The distribution of both ␤I⌺* spectrin and Ank G119 overlapped that of giantin (a 376-kDa Golgi-specific membrane protein) (3, 25) , with areas of colocalization and additional regions enriched in spectrin but devoid of giantin (Fig.  1) .
The Small GTPase ARF Regulates the Association of a Spectrin-Ankyrin Skeleton to the Golgi. The association between spectrin and the Golgi complex was characterized in permeabilized NRK cells. Golgi ␤I⌺* spectrin partially redistributed into the cytoplasm upon permeabilization, but regained its perinuclear location in the presence of the G protein activator GTP␥S (Fig. 1) , mirroring the behavior of ␤-COP and giantin. This effect of GTP␥S was blocked by BFA ( Fig.  1) , indicating that spectrin localized to the Golgi in a G protein-dependent and BFA-sensitive manner. These sensitivities paralleled those of ARF, a small G protein activated by nucleotide exchange on Golgi fractions (26, 27) and implicated ARF in the control of spectrin-Golgi binding. To assess the role of ARF, the GTP␥S-and BFA-sensitive binding of ␤I⌺* spectrin to isolated Golgi fractions was reconstituted and characterized in vitro by using subcellular fractions both from NRK cells and rat brain or liver (9, 10) . When Golgi fractions were incubated with cytosol, a discrete set of proteins at Ϸ 220, 170, 110, 108, 43, 30, and 20 kDa was recruited in a GTP␥S-dependent and BFA-sensitive manner ( Fig. 2A , ‫.)ء‬ GTP also was able to recruit the same set of proteins onto Golgi fractions in a BFA-sensitive manner, but with lower potency and efficacy compared with GTP␥S (not shown). The 20-and 110-kDa proteins were identified by immunoblotting as ARF and ␤-COP, respectively. The 220-kDa protein was identified as ␤I⌺* spectrin, recognized by the panel of anti-␤I spectrin antibodies, including two antibodies specific for the ⌺2 splicing variant of ␤I spectrin but not by the anti-␤II spectrin antibody. The profile of ␤I⌺* spectrin binding to subcellular membranes precisely overlapped with the profile of the Golgi marker mannosidase II and clearly was dissociated from plasma membrane or ER markers (not shown). The 108-and 43-kDa proteins were identified immunologically as Ank G119 and actin, respectively. Centractin was associated with the Golgi fractions as previously noted (7), but its binding was not stimulated by activated ARF (not shown). The GTP␥S-dependent and BFAsensitive association of the above proteins with Golgi was confirmed in experiments in which the membranes were recovered by flotation on sucrose gradient (Table 1) .
FIG. 1.
Golgi ␤I⌺* spectrin contains PH domain epitopes and binds the Golgi complex in a GTP␥S-dependent fashion. Four antispectrin antibodies were used to assess the distribution of the Golgiassociated spectrin. Two of these antibodies, MUS1 and MUS2, were specific for the PH domain of ␤I⌺2 spectrin. All gave similar distributions in NRK cells; the pattern of MUS1 staining is shown. This pattern largely overlaps that of giantin and is disrupted by BFA, and its reassembly is stimulated by GTP␥S in permeabilized NRK cells. The ARF requirement for binding between spectrin and Golgi was tested by using two approaches: the depletion of ARF and the selective activation of ARF achieved through a two-step incubation. In the presence of an ARF-depleted cytosol (Fig. 2B) , GTP␥S lost its ability to recruit spectrin, ␤-COP, or actin to Golgi; this activity was restored by purified ARF (14) (Fig. 2B) . The two-step binding experiments confirmed the ARF requirement for spectrin association with Golgi fractions (Fig. 2C) . Golgi fractions, washed with 1 M KCl to assure the removal of residual ARF, were incubated with or without purified bovine ARF and͞or GTP␥S in the first step, and then incubated with cytosol in the absence of GTP␥S in the second step. Only membranes preincubated with ARF and GTP␥S recruited spectrin, ␤-COP, Ank G119 , and actin, indicating that the GTP␥S-induced binding of spectrin (and several other proteins) is strictly and specifically ARF dependent (Fig. 2C) . Interestingly, the recruitment efficiency of the ARF-preloading protocol vs. the single-step addition of GTP␥S to the cytosol was similar for spectrin, ␤-COP, and ankyrin, but lower for actin, consistent with the possibility that cytosolic G proteins other than ARF also may promote actin binding and͞or polymerization.
Spectrin Binding to Golgi Fractions Occurs Independently of COPI and Involves MAD1 and MAD2. To assess whether the COPI coat played a role in the ARF-dependent binding of spectrin to Golgi, binding experiments were repeated by using a COPI-depleted cytosol. Using this ␤-COP (and hence COPI) depleted cytosol with fresh Golgi fractions and added ARF; spectrin, Ank G119 , and actin all bound just as well as with the control (undepleted) cytosol (Fig. 3A) . Thus, ARF regulates the assembly of spectrin and coatomer complexes on Golgi by distinct mechanisms.
Spectrin can associate with membranes by both adaptermediated and direct binding mechanisms (28) . In ␤I⌺2 spectrin in vitro studies have identified two direct MADs, MAD1 and MAD2 (17) . MAD1 is confined to spectrin repeat unit 1, whereas MAD2 encompasses most of spectrin's domain III and includes its PH domain (Fig. 3B) . Because the Golgiassociated ␤I⌺* spectrin shares a close antigenic similarity to ␤I⌺2 spectrin, the role of MAD1 and MAD2 in the ARFdependent recruitment of ␤I⌺* spectrin to Golgi fractions was of interest. Recombinant GST-fused polypeptides spanning MAD1 or MAD2 of ␤I⌺2 spectrin each individually inhibited the binding of ␤I⌺* spectrin (as well as that of Ank G119 and actin) to Golgi fractions (Fig. 3B) . mAbVIIIC7 also potently inhibited the binding of ␤I⌺* spectrin, Ank G119 , and actin (IC 50 Ϸ 0.2 g͞ml). In contrast, none of the fusion proteins or mAbVIIIC7 affected the binding of ␤-COP (Fig. 3B) or ARF (not shown), suggesting that spectrin binding occurs independently of COPI coat assembly.
ARF Regulates the Association of Spectrin to the Golgi by Controlling the Levels of PtdInsP 2 . Because polypeptides encompassing spectrin's MAD2 include a PH domain that binds PtdInsP 2 in vitro (29), we examined the involvement of PtdInsP 2 in Golgi-spectrin association. Recombinant GSTfused polypeptides containing PH domains known to bind PtdInsP 2 also were tested, including those from ␤II spectrin (30), the OSBP (18), and Btk (which only weakly binds PtdInsP 2 and preferentially binds PtdInsP 3 , refs. 19 and 31). The PH domains from ␤II spectrin and OSBP both inhibited the association of ␤I⌺* spectrin to Golgi, whereas Btk-PH did not (Fig. 4A) . The ineffectiveness of Btk-PH and the observation that 20 nM wortmannin (an inhibitor of PtdIns3 kinase) did not affect spectrin binding suggested a preferential role for PtdInsP 2 (vs. PtdInsP 3 ) in spectrin binding.
If PtdInsP 2 was involved in mediating the spectrin-Golgi complex interaction, ARF might control this interaction by modulating the levels of PtdInsP 2 in Golgi membranes. To test (Fig. 4B) . The presence of ARF and GTP␥S in the first step (but not GTP␥S or ARF alone) elicited a 5-fold increase in PtdInsP 2 during the second step (Fig. 4B ). Next, we tested to see whether the PtdInsP 2 synthesized in response to ARF activation was required for the association of ␤I⌺* spectrin with Golgi. The antibiotic neomycin, which sequesters PtdInsP 2 with high affinity (32), abolished ARF-induced binding of spectrin to Golgi fractions with an IC 50 of Ϸ150 M (Fig.  4C ) but did not affect the binding of ARF or ␤-COP (not shown). The inhibition by neomycin appeared to be caused by PtdInsP 2 sequestration, because it could be completely reversed by the administration of exogenous PtdInsP 2 . Interestingly, PtdInsP 2 was insufficient alone (in the absence of activated ARF) to recruit spectrin (Fig. 4C) . Adenosine (a blocker of the PtdIns4 kinase responsible for the synthesis of PtdIns4P, the precursor of PtdIns4,5P 2 , ref. 33 ) also inhibited ARF-dependent PtdInsP 2 generation and spectrin binding (Fig. 4 B and D) . Broad spectrum protein kinase inhibitors and MAD2 the regions of direct membrane association. Golgi (10 g͞sample) were incubated for 15 min at 37°C with cytosol (75 g͞sample) and 20 M GTP␥S with 3 M GST (empty bars) or GST-fused polypeptides illustrated in the schematic representation of spectrin, i.e., ␤IN-4 or ␤IN-9 from ␤I spectrin (encompassing MAD1) or ␤I⌺2DIII (encompassing MAD2, and hence the third domain of ␤I⌺ 2 spectrin containing the PH domain) (7, 16) or the anti-␤I spectrin mAb mAbVIIIC7 (0.4 g͞ml) (filled bars). Two control mAbs had no effect. The GTP␥S-induced binding of ARF was not changed by any of the reported treatments (not shown). Binding is expressed as percent of control (GST alone). Data represent the average of four experiments (Ϯ1 SD). The IC50 measured for ␤I⌺2DIII is 1 M. Golgi fractions were incubated in the first step with 1 M ARF and 20 M GTP␥S, then pelleted, rinsed, and incubated with cytosol in the second step. The buffer used in both steps contained 500 M ATP (empty bars), 500 M ATP and 2.5 mM adenosine (striped bars), or no ATP (filled bars). Results (binding to Golgi) are expressed as percent of controls (500 M ATP alone), averaged over four experiments (error bars Ϯ1 SD). (E) Golgi were incubated with GTP␥S and ARF under control conditions (a), in the presence of 1% 1-butanol (b), or 2-butanol (inactive as PLD substrate) (c). Membranes were pelleted and incubated with cytosol and 1-butanol (b) or 2-butanol (c). Golgi fractions were incubated with 0.2 units͞ml of PLD from Streptomyces chromofuscus in the absence (d) or in the presence of 100 M Ca 2ϩ (e), pelleted, rinsed, and incubated with cytosol and PLD in the second step in the absence (d) or in the presence of 1 M Ca 2ϩ (e). In parallel experiments (not shown) the levels of phosphatidic acid levels were measured as in B, and a 10-fold increase in phosphatidic acid was measured in samples treated with exogenous PLD compared with control samples. Results (␤I⌺* spectrin binding to Golgi) are expressed as percent of controls (ARF and GTP␥S). Each data represent the average of four experiments (Ϯ1 SD).
FIG. 4. ARF stimulation increases PtdInsP2 in Golgi fractions
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Cell Biology: Godi et al. Proc. Natl. Acad. Sci. USA 95 (1998) such as staurosporine, H89, and genistein had no effect on spectrin's binding (not shown). Consistent with a requirement for neo-synthesized PtdInsP 2 is the observation that the binding of spectrin, but not that of ARF or ␤-COP, to Golgi fractions was strictly ATP dependent (Fig. 4D) .
A moderate stimulatory effect of ARF on PtdInsP 2 synthesis has been reported in HL-60 cells (34) and has been attributed to ARF stimulation of phospholipase D (PLD). However, PLD stimulation did not appear to be the mechanism by which ARF induced spectrin recruitment in the system studied here, because neither 1-butanol or ethanol (inhibitors of the formation of phosphatidic acid by PLD) (35) specifically affected the ARF stimulation of binding, nor did the addition of exogenous PLD (36) stimulate binding (Fig. 4E) .
Spectrin Binding to the Golgi Complex Is Required for ER to Golgi Transport of the VSV-G Protein. Given that at least two sites by which spectrin binds to Golgi had been identified, it was of interest to determine whether binding at either or both sites is required for Golgi function. To this end we used the above-described recombinant peptides or antibodies to block the assembly of native Golgi spectrin in semi-intact VSV-infected NRK cells and measured the ER to Golgi transport of VSV-G protein. Under control conditions 60% and 80% of VSV-G protein was transported at 32°C from the ER to the Golgi after 60 and 90 min, respectively (Fig. 5) . These values are similar to those observed by others (21) . With the exception of Btk, all fusion proteins and mAbVIIIC7 suppressed transport of VSV-G from the ER to medial Golgi (Fig. 5A) . The MAD1-encompassing polypeptide was the most effective inhibitor of transport, in agreement with in vivo transfection data obtained in MDCK cells (7) . None of the above agents, added after 60 min at 32°C under control conditions (to let the VSV-G protein reach the medial Golgi), affected the trans-Golgi͞trans-Golgi network (TGN) arrival of VSV-G (Fig. 5B) . Thus, it appears that spectrin binding to the Golgi is required for VSV-G transport from the ER to Golgi, but not for its subsequent transport to the trans-Golgi͞TGN.
DISCUSSION
The association of spectrin with membranes is multivalent and cooperative and involves both direct and adapter-mediated membrane attachment sites (17) . Based on the data presented here and previous data, we envisage that the binding of spectrin to Golgi membranes involves at least two binding domains, one (MAD1) bearing a targeting signal (7) and responsible for constitutive localization to the Golgi complex, and one (MAD2) acting to enhance the affinity of this binding and to render it sensitive to PtdInsP 2 regulation. Because the overall affinity of such a two-site interaction equals the product of the affinities of each individual site, it is conceivable that the most stable spectrin-membrane associations are achieved only at Golgi-specific docking sites where, and when, the local density of PtdInsP 2 reaches a threshold necessary to engage the spectrin PH domain (i.e., MAD2). It is also possible that interactions mediated by other adapter proteins, such as ankyrin, contribute to Golgi binding given their prominence as a membrane linker in the erythrocyte membrane skeleton. Finally, although a growing body of evidence indicates that phosphoinositides are essential to the function of the secretory apparatus (37), the molecular mechanisms and the targets of phosphoinositides remain uncertain. Our results indicate that PtdInsP 2 is required for the ARF-dependent association of ␤I⌺* spectrin to the Golgi complex.
The data reported here together with data reported in parallel studies in transfected cells (7) demonstrate that the association of spectrin to Golgi is required for ER to Golgi transport. However, the precise role of spectrin in Golgi function remains to be defined. Spectrin does not belong to any of the known classes of proteins so far implicated in the management of protein traffic in the secretory pathway. Two nonmutually exclusive models can be proposed at this time. Spectrin might function as a novel type of vesicular coat, mediating the capture and anterograde transport of specific cargo molecules between the ER and Golgi (7) . In this model, spectrin also might mediate the interaction between Golgi membranes and the machinery of dynein-driven transport by direct binding to the dynactin complex (7, 38) . Another attractive role of the spectrin-based Golgi skeleton, considering spectrin's established role at the plasma membrane to guarantee structural integrity and organize membrane domains, could be to organize incoming ER-derived membranes into a cis-Golgi compartment (39) . Such a function would be particularly appealing in the context of recently proposed versions of the cisternal progression-maturation model (40, 41) that envisage the existence of a dynamic Golgi scaffold able to undergo rapid remodeling to integrate the new membranes coming from pre-Golgi compartments, and to release Golgi membranes destined to post-Golgi compartments. Within this framework it is difficult to distinguish a pure ''structural'' from a ''functional'' role of spectrin in the Golgi complex: the block of spectrin association, caused in our experiments by competing peptides and antibodies, would impair the organization and integration of incoming ER-derived membranes into the Golgi complex, thereby inhibiting transport of cargo molecules from the ER.
It has long been clear that some kind of matrix or skeleton must play a critical role in maintaining the structure and function of the Golgi complex. Studies with BFA and mitotic Golgi (1, 24, 42) indicate that the Golgi skeleton must be dynamic and controlled by ARF, able to quickly disassemble and reassemble. The studies reported reveal the identity of Fig. 3B, i. e., ␤IN-4 (b), ␤IN-9(c), MAD2 (containing the PH domain) of ␤I⌺2 spectrin (d), 3 M GST-fused PH domains of ␤II spectrin (e), or Btk ( f) for 90 min at 32°C. g indicates samples that, after the pulse at 40°C, were maintained on ice for the next 90 min. The anti-␤I spectrin mAb mAbVIIIC7 (at the indicated concentrations) was preincubated with permeabilized cells for 45 min on ice after the 40°C incubation, before the shift to 32°C. Two control mAbs had no effect. Results are expressed as percent of controls (a). (B) Intra-Golgi transport. After pulse and permeabilization, NRK cells were shifted to 32°C for 60 min (to let the VSV-G protein reach the medial-Golgi), then transferred to 4°C, and after the addition of the agents specified in A, shifted again to 32°C for 90 min. g indicates samples that, after the pulse at 40°C and 60 min at 32°C, were kept on ice for the next 90 min. Results are expressed as percent of controls (a). Data represent the average of four experiments (Ϯ1 SD). such a skeleton, define one mechanism by which it is regulated, and define useful biochemical approaches to further dissect its function.
